Figure 1.
Plasma total bile acids (BA), conjugated BA and unconjugated BA at baseline, during 4-week dose escalation period and after 2-week follow-up in otherwise healthy hypercholesterolemic subjects consuming L. reuteri NCIMB 30242 in delayed release capsules (left column) or standard capsules (right column). Each timepoint is represented by individual values and mean ± SEM. Significantly different from baseline (*P ˂ 0.05).